AbClon (174900 KS)

Health Care • South Korea

AbClon Inc. operates as a biotechnology company. The Company develops antibody drugs for the treatment of stomach, colorectal, and lung cancer. AbClon also provides antigen and monoclonal antibody services. AbClon markets its products worldwide.

Refresh

Focused

No publications yet

There aren’t any podcasts right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00